ORAGENICS, INC. Deferred Tax Assets, Deferred Income
ORAGENICS, INC. (OGEN) had Deferred Tax Assets, Deferred Income of $8.73 thousand as of 2012-12-31, per its 10-K filed 2014-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2014-02-28
- 2012-12-31: Deferred Tax Assets, Deferred Income $8.73K.
- 2011-12-31: Deferred Tax Assets, Deferred Income $13.19K.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2012-12-31 | $8.73K 10-K · filed 2014-02-28 |
| 2011-12-31 | $13.19K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |